These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 21436014)
1. Effects of different peritoneal dialysis fluids on the TH1/TH2 balance. Libetta C; Esposito P; Sepe V; Guastoni C; Zucchi M; Meloni F; Dal Canton A Eur Cytokine Netw; 2011 Mar; 22(1):24-31. PubMed ID: 21436014 [TBL] [Abstract][Full Text] [Related]
2. Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo. Bajo MA; del Peso G; Castro MA; Díaz C; Castro MJ; Gil F; Sánchez-Tomero JA; Selgas R Adv Perit Dial; 2001; 17():37-41. PubMed ID: 11510293 [TBL] [Abstract][Full Text] [Related]
3. Cytokines and peritonitis in continuous ambulatory peritoneal dialysis: immunodeviation and immunodeficiency. Klínger J; Enríquez J; Arturo JA; Delgado M; Avila G; Ceballos O Adv Perit Dial; 2002; 18():170-6. PubMed ID: 12402613 [TBL] [Abstract][Full Text] [Related]
4. Peritoneal T cell responses can be polarized toward Th1 or Th2 in children on chronic peritoneal dialysis. Chiesa S; Vigo G; Cappa F; Prigione I; Pistoia V; Verrina E; Perfumo F; Barbano G Artif Organs; 2004 Aug; 28(8):750-2. PubMed ID: 15270959 [TBL] [Abstract][Full Text] [Related]
5. Peritonitis in continuous ambulatory peritoneal dialysis: cytokines in peritoneal fluid and blood. Enríquez J; Klínger J; Arturo JA; Delgado M; Tobar C; Mosquera M Adv Perit Dial; 2002; 18():177-83. PubMed ID: 12402614 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-12 and -18 levels in peritoneal dialysate effluent correlate with the outcome of peritonitis in patients undergoing peritoneal dialysis: implications for the Type I/Type II T-cell immune response. Wang HH; Lin CY Am J Kidney Dis; 2005 Aug; 46(2):328-38. PubMed ID: 16112053 [TBL] [Abstract][Full Text] [Related]
7. Acute effects of peritoneal dialysis solutions in the mesenteric microcirculation. Frajewicki V; Brod V; Kushnir D; Kohan R; Bitterman H Transl Res; 2009 May; 153(5):249-56. PubMed ID: 19375686 [TBL] [Abstract][Full Text] [Related]
8. Bicarbonate/lactate dialysis solution improves in vivo function of peritoneal host defense in rats. Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Faict D; Holmes CJ; Breborowicz A Perit Dial Int; 1999; 19 Suppl 2():S370-7. PubMed ID: 10406549 [TBL] [Abstract][Full Text] [Related]
9. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study. Fusshoeller A; Plail M; Grabensee B; Plum J Nephrol Dial Transplant; 2004 Aug; 19(8):2101-6. PubMed ID: 15213322 [TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro effects of amino-acid-based and bicarbonate-buffered peritoneal dialysis solutions with regard to peritoneal transport and cytokines/prostanoids dialysate concentrations. Plum J; Fusshöller A; Schoenicke G; Busch T; Erren C; Fieseler C; Kirchgessner J; Passlick-Deetjen J; Grabensee B Nephrol Dial Transplant; 1997 Aug; 12(8):1652-60. PubMed ID: 9269644 [TBL] [Abstract][Full Text] [Related]
11. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH. Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741 [TBL] [Abstract][Full Text] [Related]
12. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Nishina M; Endoh M; Suzuki D; Tanabe R; Endoh H; Hirahara I; Sakai H Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033 [TBL] [Abstract][Full Text] [Related]
13. Polarization of T-helper lymphocytes toward the Th2 phenotype in uremic patients. Libetta C; Rampino T; Dal Canton A Am J Kidney Dis; 2001 Aug; 38(2):286-95. PubMed ID: 11479154 [TBL] [Abstract][Full Text] [Related]
15. An amino acid-based peritoneal dialysis fluid buffered with bicarbonate versus glucose/bicarbonate and glucose/lactate solutions: an intraindividual randomized study. Plum J; Erren C; Fieseler C; Kirchgessner J; Passlick-Deetjen J; Grabensee B Perit Dial Int; 1999; 19(5):418-28. PubMed ID: 11379854 [TBL] [Abstract][Full Text] [Related]
16. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability. Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115 [TBL] [Abstract][Full Text] [Related]
17. Relationship between amiodarone-induced subclinical lung toxicity and Th1/Th2 balance. Kuruma T; Maruyama T; Hiramatsu S; Yasuda Y; Yasuda S; Odashiro K; Harada M Int J Cardiol; 2009 May; 134(2):224-30. PubMed ID: 18584899 [TBL] [Abstract][Full Text] [Related]
18. Short-term effects of a new bicarbonate/lactate-buffered and conventional peritoneal dialysis fluid on peritoneal and systemic inflammation in CAPD patients: a randomized controlled study. Pajek J; Kveder R; Bren A; Gucek A; Ihan A; Osredkar J; Lindholm B Perit Dial Int; 2008; 28(1):44-52. PubMed ID: 18178947 [TBL] [Abstract][Full Text] [Related]
19. Biocompatible peritoneal dialysis solutions: do they indeed affect the outcome? Grzegorzewska AE Pol Arch Med Wewn; 2009 Apr; 119(4):242-7. PubMed ID: 19413184 [TBL] [Abstract][Full Text] [Related]
20. Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis. Montenegro J; Saracho R; Gallardo I; Martínez I; Muñoz R; Quintanilla N Nephrol Dial Transplant; 2007 Jun; 22(6):1703-8. PubMed ID: 17405794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]